Designing First-in-Human Oncology Phase I Trials
Designing First-in-Human Oncology Phase I Trials How to Successfully Design and Execute First-in-Human Oncology Phase I Trials Introduction to First-in-Human Oncology Phase I Trials First-in-Human (FIH) oncology Phase I trials mark the first administration of a novel anti-cancer agent to human subjects. These studies are distinct from non-oncology trials because they typically enroll patients with…
Read More “Designing First-in-Human Oncology Phase I Trials” »